Cargando…

Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor

Detalles Bibliográficos
Autor principal: Coleman, RE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284880/
http://dx.doi.org/10.1186/bcr2277
_version_ 1782351483552923648
author Coleman, RE
author_facet Coleman, RE
author_sort Coleman, RE
collection PubMed
description
format Online
Article
Text
id pubmed-4284880
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42848802015-01-15 Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor Coleman, RE Breast Cancer Res Oral Presentation BioMed Central 2009 2009-06-23 /pmc/articles/PMC4284880/ http://dx.doi.org/10.1186/bcr2277 Text en Copyright © 2009 BioMed Central Ltd.
spellingShingle Oral Presentation
Coleman, RE
Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor
title Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor
title_full Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor
title_fullStr Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor
title_full_unstemmed Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor
title_short Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor
title_sort targeting the tumour microenvironment: denosumab, a new rankl inhibitor
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284880/
http://dx.doi.org/10.1186/bcr2277
work_keys_str_mv AT colemanre targetingthetumourmicroenvironmentdenosumabanewranklinhibitor